Article navigation

Relonics, for the first time, identifies previously unknown multi‐dimensional patterns of biochemical meta‐networks which can serve as specific and sensitive systemic markers for categorical prediction of acute chest pain outcome in individual patients at the time of admission in Intensive Care Unit.

You do not currently have access to this content.
Don't already have an account? Register

Purchased this content as a guest? Enter your email address to restore access.

Pay-Per-View Access
$41.00
Rental

or Create an Account

Close subscription notice
Close access options